Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

186.39
-3.4900-1.84%
Post-market: 187.000.6100+0.33%18:28 EDT
Volume:6.73M
Turnover:1.25B
Market Cap:329.24B
PE:79.66
High:190.67
Open:190.21
Low:185.01
Close:189.88
Loading ...

AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
1 hour ago

AbbVie’s New Phase 2 Study on Psoriatic Arthritis: What Investors Need to Know

TIPRANKS
·
6 hours ago

AbbVie’s CLL Study: Enhancing Patient Well-being with Oral Treatments

TIPRANKS
·
6 hours ago

AbbVie’s New Study on Targeted Therapies for Rheumatoid Arthritis: A Market Game Changer?

TIPRANKS
·
6 hours ago

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS)

TIPRANKS
·
Yesterday

AbbVie’s Innovative Approach to Crohn’s Disease: A Study Update

TIPRANKS
·
Yesterday

AbbVie’s SWITCH-UP Study: A New Hope for Atopic Dermatitis Treatment?

TIPRANKS
·
Yesterday

AbbVie’s Phase 3 Study on Upadacitinib for SLE: Key Insights for Investors

TIPRANKS
·
Yesterday

AbbVie’s ABBV-101 Study: A New Hope for B-Cell Malignancies?

TIPRANKS
·
Yesterday

AbbVie’s CLL Study: A Potential Game-Changer in Cancer Treatment?

TIPRANKS
·
Yesterday

Abbvie and Genmab’s Promising Study on Epcoritamab for Lymphoma: A Financial Perspective

TIPRANKS
·
Yesterday

AbbVie Inc. Files Initial Statement of Beneficial Ownership by EVP and Chief HR Officer Demetris D. Crum

Reuters
·
12 Jul

AbbVie Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
12 Jul

INDIA STOCKS-India's equity benchmarks log weekly losses as IT stocks drag

Reuters
·
11 Jul

Glenmark Pharma Shares up 10% in Pre-Open Trade After Unit, Abbvie Ink Licensing Deal

THOMSON REUTERS
·
11 Jul

AbbVie (ABBV) Laps the Stock Market: Here's Why

Zacks
·
11 Jul

AbbVie Inc. (ABBV): A Bull Case Theory

Insider Monkey
·
11 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
11 Jul

AbbVie and Genmab’s Epcoritamab Trial: A Promising Update for B-NHL Treatment

TIPRANKS
·
11 Jul

BUZZ-AbbVie rises after licensing deal for cancer treatment with India's Glenmark Pharma unit

Reuters
·
10 Jul